Flint Alexander C, Conell Carol, Klingman Jeff G, Rao Vivek A, Chan Sheila L, Kamel Hooman, Cullen Sean P, Faigeles Bonnie S, Sidney Steve, Johnston S Claiborne
Department of Neuroscience, Kaiser Permanente, Redwood City, CA Division of Research, Kaiser Permanente Northern California, Oakland, CA
Division of Research, Kaiser Permanente Northern California, Oakland, CA.
J Am Heart Assoc. 2016 Jul 29;5(8):e003413. doi: 10.1161/JAHA.116.003413.
Statin administration early in ischemic stroke may influence outcomes. Our aim was to determine the clinical impact of increasing statin administration early in ischemic stroke hospitalization.
This is a retrospective analysis of a multicenter electronic medical record (EMR) intervention to increase early statin administration in ischemic stroke across all 20 hospitals of an integrated healthcare delivery system. A stroke EMR order set was modified from an "opt-in" to "opt-out" mode of statin ordering. Outcomes were mortality by 90 days, discharge disposition, and increase in stroke severity. We examined the relationship between intervention and outcome using autoregressive integrated moving average (ARIMA) time-series modeling. The EMR intervention increased both overall in-hospital statin administration (from 87.2% to 90.7%, P<0.001) and early statin administration (from 16.9% to 26.3%, P<0.001). ARIMA models showed a small increase in the rate of survival (difference in probability [Pdiff]=0.02, P=0.016) and discharge to home or rehabilitation facility (Pdiff=0.04, P=0.034) associated with the intervention. The increase in statin administration <8 hours was associated with much larger increases in survival (Pdiff=0.17, P=0.033) and rate of discharge to home or rehabilitation (Pdiff=0.29, P=0.011), as well as a decreased rate of neurological deterioration in-hospital (Pdiff=-0.14, P=0.026).
A simple EMR change increased early statin administration in ischemic stroke and was associated with improved clinical outcomes. This is, to our knowledge, the first EMR intervention study to show that a modification of an electronic order set resulted in improved clinical outcomes.
在缺血性卒中早期使用他汀类药物可能会影响预后。我们的目的是确定在缺血性卒中住院早期增加他汀类药物使用的临床影响。
这是一项对多中心电子病历(EMR)干预措施的回顾性分析,该干预措施旨在增加综合医疗服务系统中所有20家医院缺血性卒中患者早期他汀类药物的使用。卒中EMR医嘱集从他汀类药物订购的“选择加入”模式改为“选择退出”模式。观察指标包括90天死亡率、出院转归以及卒中严重程度的增加情况。我们使用自回归积分移动平均(ARIMA)时间序列模型研究干预措施与观察指标之间的关系。EMR干预措施提高了院内他汀类药物的总体使用率(从87.2%提高到90.7%,P<0.001)以及早期他汀类药物的使用率(从16.9%提高到26.3%,P<0.001)。ARIMA模型显示,与干预措施相关的生存率有所提高(概率差异[Pdiff]=0.02,P=0.016),出院回家或康复机构的比例也有所提高(Pdiff=0.04,P=0.034)。在8小时内使用他汀类药物的增加与生存率的大幅提高(Pdiff=0.17,P=0.033)、出院回家或康复机构的比例增加(Pdiff=0.29,P=0.011)以及院内神经功能恶化率降低(Pdiff=-0.14,P=0.026)相关。
一项简单的EMR更改增加了缺血性卒中患者早期他汀类药物的使用,并与改善临床预后相关。据我们所知,这是第一项显示电子医嘱集修改可改善临床预后的EMR干预研究。